journal article·2010-04Open access

Characterization of dextrin‐based hydrogels: Rheology, biocompatibility, and degradation

Joana Carvalho, Susana Moreira, João Maia, Francisco M. Gama

Abstract

Abstract A new class of degradable dextrin‐based hydrogels (dextrin‐HEMA) was developed. The hydroxyethyl methacrylate ester (HEMA) hydroxyl groups were activated with N,N′‐carbonyldiimidazole (CDI), followed by their coupling to dextrin, yielding a derivatized material that can be polymerized in aqueous solution to form hydrogels. A comparative study of the stability of the dextrin‐HEMA hydrogels and dextrin‐vinyl acrylate (dextrin‐VA, produced in previous work) revealed that only the firsts are effectively hydrolyzed under physiological conditions. A severe mass loss of dextrin‐HEMA gels occurs over time, culminating in the complete dissolution of the gels. Rheologic analysis confirmed that physical structuring is less pronounced when dextrin is modified with methacrylate side groups. The biocompatibility results revealed that the dextrin hydrogels have negligible cell toxicity, irrespective of the hydrogel type (HEMA and VA), allowing cell adhesion and proliferation. Gathering the biocompatibility and the ability to tailor the release profiles, we consider dextrin a promising biomaterial for biomedical applications, namely for controlled release. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res 2010
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Polysaccharides Composition and Applications · 3D Printing in Biomedical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (47)

Show source-provided references
1. 10.1002/pola.1994.08032070810.1002/pola.1994.080320708 ↗
2. Peppas NA · 1996
3. Kane JB · 1996
4. 10.1021/bk-1998-070910.1021/bk-1998-0709 ↗
5. 10.1016/S0939-6411(00)00090-410.1016/S0939-6411(00)00090-4 ↗
6. 10.1016/S0142-9612(03)00096-610.1016/S0142-9612(03)00096-6 ↗
7. 10.1016/S0142-9612(03)00340-510.1016/S0142-9612(03)00340-5 ↗
8. 10.1046/j.1524-475x.2001.00513.x10.1046/j.1524-475x.2001.00513.x ↗
9. 10.1002/app.1992.07046030510.1002/app.1992.070460305 ↗
10. 10.1016/0966-7822(94)00006-S10.1016/0966-7822(94)00006-S ↗
11. 10.3109/0265204910906956010.3109/02652049109069560 ↗
12. 10.1016/S1381-5148(97)00047-310.1016/S1381-5148(97)00047-3 ↗
13. 10.1016/0142-9612(94)90120-110.1016/0142-9612(94)90120-1 ↗
14. 10.1016/S0142-9612(97)00164-610.1016/S0142-9612(97)00164-6 ↗
15. 10.1021/ma00122a04410.1021/ma00122a044 ↗
16. 10.1021/ma970401810.1021/ma9704018 ↗
17. 10.1021/ma961764v10.1021/ma961764v ↗
18. 10.1016/S0032-3861(97)00189-410.1016/S0032-3861(97)00189-4 ↗
19. 10.1021/js960422010.1021/js9604220 ↗
20. 10.1021/bm010150h10.1021/bm010150h ↗
21. 10.1016/S0142-9612(02)00132-110.1016/S0142-9612(02)00132-1 ↗
22. 10.1016/j.eurpolymj.2007.02.04610.1016/j.eurpolymj.2007.02.046 ↗
23. 10.1021/ma011408z10.1021/ma011408z ↗
24. 10.1016/0022-1759(89)90397-910.1016/0022-1759(89)90397-9 ↗
25. 10.1016/0092-8674(94)90131-710.1016/0092-8674(94)90131-7 ↗
26. The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts
27. 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B ↗
28. 10.1016/S0169-409X(01)00239-310.1016/S0169-409X(01)00239-3 ↗
29. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
30. Flory PJ · 1953
31. 10.1016/S0032-3861(02)00561-X10.1016/S0032-3861(02)00561-X ↗
32. 10.1163/156856298X0007310.1163/156856298X00073 ↗
33. 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K ↗
34. Wong WH · 1997 · 49
35. 10.1016/0142-9612(96)87644-710.1016/0142-9612(96)87644-7 ↗
36. 10.1021/ma992131u10.1021/ma992131u ↗
37. Ferry JD · 1980
38. 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L ↗
39. 10.1002/jbm.a.2010210.1002/jbm.a.20102 ↗
40. Biocompatible and degradable biocatalytic dextran hydrogels
41. 10.1002/jbm.82029061010.1002/jbm.820290610 ↗
42. 10.1016/S0142-9612(99)00270-710.1016/S0142-9612(99)00270-7 ↗
43. 10.1016/S0142-9612(00)00266-010.1016/S0142-9612(00)00266-0 ↗
44. Regulation of hyaluronic acid synthesis in human saphenous vein smooth muscle cells by interleukin‐1 and prostaglandins
45. 10.1002/jbm.1006110.1002/jbm.10061 ↗
46. 10.1002/jbm.a.3099810.1002/jbm.a.30998 ↗
47. CarvalhoJ CoimbraMA GamaFM.New dextrin‐vinylacrylate hydrogel: Studies on protein diffusion and release Carbohydr Polym2009;75:322–327.10.1016/j.carbpol.2008.07.033 ↗